I also think that two things people have been complaining about can logically co-exist. First, the company main fact be making progress ‘on all fronts’, eg the vaccine, excellagen, etc while at the same time remaining ‘silent’. Let’s suppose the company received a letter from the SEC this summer which raised a significant though defensible issue...but one which requires both focused and immediate attention including changes in the way they manage corporate affairs. And let’s say that that SEC complaint...which might threaten their going concern status...had to be addressed, and that the response and changes in corporate operations could take months. But concurrently the company decides that they will be able to satisfy the SEC. so they decide to keep trudging forward with vaccine development, manufacturing Excellagen etc...but do not dare communicate to the general public their current ‘hot water’ status until the shoes have finally dropped or the problem has been solved. Communication is tricky during such a stretch...do we promote our progress even before satisfying the SEC? Would we be misleading shareholders about the good times ahead if we are at risk of ceasing operations resulting from an SEC complaint?
I don’t know that this scenario captures what is occurring ‘behind the curtain’, or in the box that Zolis reminds us about, but things can be more complicated...and explainable...than we frequently are able to imagine.
(5)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links